STREAMEX CORP. Retained Earnings
STREAMEX CORP. (STEX) had Retained Earnings of -$779.37 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$779.37M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$764.81M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$718.12M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$294.11M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$779.37M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$764.81M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | -$718.12M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$294.11M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$278.53M 10-Q · filed 2025-08-15 | |
| 2025-03-31 | -$258.16M 10-Q · filed 2025-05-19 | |
| 2024-12-31 | -$255.34M 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$254.25M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$252.33M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$248.42M 10-Q · filed 2024-05-20 | |
| 2023-12-31 | -$245.01M 10-K · filed 2025-04-15 | |
| 2023-09-30 | -$238.97M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$234.40M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$223.31M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$215.97M 10-K · filed 2024-04-16 | |
| 2022-09-30 | -$209.02M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$202.64M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | -$196.88M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | -$188.92M 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$180.28M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$173.03M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | -$165.32M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | -$157.00M 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$146.71M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | -$135.31M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | -$116.12M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | -$104.79M 10-K · filed 2021-03-15 | -$104.79M 10-K · filed 2020-03-13 |
| 2019-09-30 | -$89.99M 10-Q · filed 2019-10-23 | |
| 2019-06-30 | -$84.55M 10-Q · filed 2019-07-31 | |
| 2019-03-31 | -$76.60M 10-Q · filed 2019-04-15 | |
| 2018-12-31 | -$70.73M 10-K · filed 2020-03-13 | |
| 2018-09-30 | -$65.04M 10-Q · filed 2018-11-02 | |
| 2018-06-30 | -$61.88M 10-Q · filed 2018-07-27 | |
| 2018-03-31 | -$56.12M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | -$56.52M 10-K · filed 2019-03-15 | |
| 2017-09-30 | -$51.98M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$50.18M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | -$47.10M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | -$43.83M 10-K · filed 2018-02-27 | |
| 2016-09-30 | -$42.45M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$40.92M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | -$34.82M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | -$32.24M 10-K · filed 2017-04-11 | |
| 2015-09-30 | -$30.22M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | -$30.59M 10-Q · filed 2015-07-28 | |
| 2015-03-31 | -$25.83M 10-Q · filed 2015-05-01 | |
| 2014-12-31 | -$22.78M 10-K · filed 2016-03-14 | |
| 2014-09-30 | -$20.10M 10-Q · filed 2014-10-17 | |
| 2014-06-30 | -$16.08M 10-Q · filed 2014-07-28 | |
| 2013-12-31 | -$14.01M 10-K · filed 2015-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |